Crucially, both apelin peptide and the receptor are upregulated in GBM patient samples, and, in an orthotopic mouse model of GBM, apelin was required for tumour vascularisation, where apelin depletion significantly reduced tumour size and increased survival of tumour-bearing mice (Frisch et al., 2020). Here, APLN is linked to neoplasm.